HIND
Vyome Holdings, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$14.81M
P/E Ratio
—
EPS
$-4.86
Beta
—
52W High
$69.80
52W Low
$1.75
50-Day MA
$2.57
200-Day MA
$5.83
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Vyome Holdings, Inc.
Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company is headquartered in Princeton, New Jersey.
Fundamentals
| Revenue (TTM) | 319,710 |
| Gross Profit (TTM) | 218,770 |
| EBITDA | $-2.74M |
| Operating Margin | -3707.00% |
| Return on Equity | 0.00% |
| Return on Assets | -43.60% |
| Revenue/Share (TTM) | $0.15 |
| Book Value | $0.41 |
| Price-to-Book | 6.18 |
| Price-to-Sales (TTM) | 46.32 |
| EV/Revenue | 31.71 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -40.50% |
| Shares Outstanding | $7.02M |
| Float | $3.25M |
| % Insiders | 33.92% |
| % Institutions | 1.55% |
Data last updated: 4/8/2026